A ribbon of brain tissue called cortical gray matter grows thinner in people who go on to develop dementia, and this appears to be an accurate biomarker of the disease five to 10 years before symptoms appear, researchers from The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) reported.
EMA committee recommends approvals for Lilly’s weight loss drug, Mirati’s KRAS inhibitor and more
The European Medicines Agency’s human medicines committee (CHMP) this week gave a thumbs-up to nine label expansions and eight new drugs, including Eli Lilly’s tirzepatide
November 11, 2023